PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 47 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $348,000 | -18.7% | 117,242 | 0.0% | 0.21% | -25.6% |
| Q2 2022 | $428,000 | -41.0% | 117,242 | 0.0% | 0.28% | -22.6% |
| Q1 2022 | $726,000 | -23.6% | 117,242 | 0.0% | 0.36% | +4.1% |
| Q4 2021 | $950,000 | -45.6% | 117,242 | 0.0% | 0.34% | -31.7% |
| Q3 2021 | $1,747,000 | -78.1% | 117,242 | 0.0% | 0.50% | -75.4% |
| Q2 2021 | $7,975,000 | +1396.2% | 117,242 | 0.0% | 2.05% | +1550.8% |
| Q1 2021 | $533,000 | +112.4% | 117,242 | 0.0% | 0.12% | +113.8% |
| Q4 2020 | $251,000 | -8.1% | 117,242 | 0.0% | 0.06% | -47.3% |
| Q3 2020 | $273,000 | +15.7% | 117,242 | 0.0% | 0.11% | +61.8% |
| Q2 2020 | $236,000 | +177.6% | 117,242 | 0.0% | 0.07% | +172.0% |
| Q1 2020 | $85,000 | -72.7% | 117,242 | 0.0% | 0.02% | -63.2% |
| Q4 2019 | $311,000 | -21.5% | 117,242 | 0.0% | 0.07% | -43.3% |
| Q3 2019 | $396,000 | -43.6% | 117,242 | 0.0% | 0.12% | -36.2% |
| Q2 2019 | $702,000 | – | 117,242 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
| Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
| Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
| INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
| REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
| Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
| tru Independence LLC | 500 | $0 | 0.00% |
| Renaissance Technologies | 120,269 | $319,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
| VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |